Argenta, the leading animal health pharmaceutical services company, is pleased to announce the appointment of Terry Jackson as the Global Head of Quality Assurance (QA) and Regulatory Affairs, effective immediately.

As a proven leader of high-performance quality organisations within the pharmaceutical industry in both human and animal health, Terry brings over 25 years of experience with leadership roles within companies such as Dechra, Catalent, and Pfizer Animal Health. Most recently, Terry was the Head of Quality of the Shawnee site which was recently acquired by Argenta.

“I am thrilled to welcome Terry to Argenta. He has a proven track record, and I believe his expertise and leadership will help enable our ability to deliver for our clients while upholding the highest standards of quality and regulatory compliance,” said Stephan Kutzer, Interim CEO and Board Member at Argenta.

Terry will join the Executive Leadership Team and oversee the QA and Regulatory Affairs organisations across our CDMO and CRO service platforms, reporting directly to the CEO.

About Argenta

Argenta is a global animal health services company, supporting companies big and small to develop and manufacture products that contribute to the health and well-being of animals. From 'molecule to market', our trusted, innovative solutions cover every stage of product development, and we are trusted by the world’s top animal health companies – who return to Argenta for our unparalleled, comprehensive support. For more information, please visit www.argentaglobal.com.

Media Contact

Annemieke de Keijzer

Global Head of Communications and Marketing

globalcommunications@argentaglobal.com

‍